Wave Life Sciences, Inc. · Brief

Next report

69 days

Jan 11 · before openest.Q4 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

May 8 '25±19.4%▲+0.77%×0.04

Jul 30 '25±18.4%▼−1.92%×0.10

Nov 10 '25±23.3%▼−10.31%×0.44

Jan 12 '26±8.6%▲+0.51%×0.06

Feb 26 '26±16.9%▲+5.64%×0.33

Q1 FY26±11.6%▲+8.36%×0.72

Q2 FY26±13.3%▼−0.86%×0.06

Q3 FY26±50.3%▲+7.48%×0.15

quarterimplied−55%0+55%realized×

Q3 FY26±50.3%▲+7.48%×0.15

Q2 FY26±13.3%▼−0.86%×0.06

Q1 FY26±11.6%▲+8.36%×0.72

Feb '26±16.9%▲+5.64%×0.33

Jan '26±8.6%▲+0.51%×0.06

Nov '25±23.3%▼−10.31%×0.44

2 older reports

Jul '25±18.4%▼−1.92%×0.10

May '25±19.4%▲+0.77%×0.04

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Jan 11 report · est.

Bull2

114managers reporting a position in the latest quarter13F · Jun 30 '26

4disclosed supplier and customer tiesSEC filings

Bear2

9 of 23largest reporting managers reduced their stake in the latest quarter13F · Jun 30 '26

9managers holding most of reported value13F · Jun 30 '26

AI captions · Nov 2 '26once per report · top 2 per case

WVE report session

No linked exposure.

Oct 26impliedImplied move: ±50.3% into Oct 27 earnings (Oct 26 close).Source

Oct 26impliedImplied move: ±50.3% into Nov 9 earnings (Oct 26 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.